0078-0628Level 3
Afinitor (everolimus)
**Product type:** Human Prescription Drug
**Active ingredient:** EVEROLIMUS
**Strength:** 5 mg/1
**Dosage form:** Tablet, For Suspension
**Route:** Oral
**Labeler:** Novartis Pharmaceuticals Corporation
**Marketing category:** NDA (NDA203985)
**Pharmacologic class:** Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0078-0628Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.